Cardiovascular protection using anti-aldosteronic progestins
View Patent ↗A composition comprises drospirenone as the sole therapeutically active agent.
1. A method for treating hypertension in a woman comprising administering drospirenone as the sole therapeutically active agent to said woman, and wherein said drospirenone is administered daily in a solid unit dosage form containing a dose of drospirenone of 2, 2.5, or 3 mg.
2. The method of claim 1 , wherein said woman is peri-menopausal
3. The method of claim 1 , wherein said woman is post-menopausal.
4. The method of claim 1 , wherein 2.5 mg of drospirenone is administered to said woman.
5. The method of claim 1 , wherein 2 mg of drospirenone is administered to said woman.
6. The method of claim 1 , wherein said drospirenone is micronized drospirenone.
7. The method of claim 6 , wherein said unit dosage form contains a dose of micronized drospirenone of 2 mg.
8. The method of claim 1 , wherein said unit dosage form contains a dose of micronized drospirenone of 3 mg.
9. The method of claim 1 , wherein said unit dosage form contains a dose of drospirenone of 3 mg.